More VPDs studies

More VPDs studies

African Local Initiative for Vaccinology Expertise (ALIVE)
AMP/HPTN 081: A phase 2b study to evaluate the safety and efficacy of VRCO1 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection (AMP)
Maternal Vaccinations: Feasibility, acceptability and potential barriers (concept needs development and funding)
Maternal-infant pairs (MIP VPD study): Antibody responses to VPDs in HIV-exposed uninfected children (awaiting funding, applied to UK MRC)
Observational Maternal/Infant influenza vaccine study
Paediatric Rotavirus (VAC041)
Phase I/II, randomised placebo controlled study of the safety and immunogenicity of Clade C ALVAC-HIV (vCP2438) and bivalent subtype C in infants (IMPAACT 2004)
Phase I/II, safety and immunogenicity study of a recombinant protient TB Vaccine (AERAS-404) in BCG-primed infants (P1113)
Safety of Respiratory Syncytial Virus for pregnant women and their children (RSV-M-301)

Subscribe to our Newsletter